iifl-logo

Natco Pharma Ltd Historical Data

863.1
(0.56%)
Jun 9, 2025|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Natco Pharma Ltd Historical Data

10/05/2025calendar-icon
10/06/2025calendar-icon
Date
Open(₹)
High(₹)
Low(₹)
Close(₹)
No. Of Trades(₹)
Total Turnover(₹)
Deliverable Quantity(₹)

12-May-2025

848.95

848.95811.55833.845,66364,65,88,548.32,60,346

13-May-2025

834

841.65821825.137,29852,80,41,659.453,18,778

14-May-2025

832

834.35819.9827.927,13539,34,87,133.82,63,317

15-May-2025

830

835821.25823.821,15538,08,98,691.52,98,912

16-May-2025

825.2

851819.05841.1532,32661,34,35,732.053,87,722

19-May-2025

843

874.3841.3866.1532,22464,70,49,792.453,25,949

20-May-2025

872.4

878.784885226,53443,25,29,5312,48,531

21-May-2025

853.1

890848875.660,7221,24,02,23,211.73,49,390

22-May-2025

883

884.4863877.327,77448,97,35,357.11,91,118

23-May-2025

879.1

884.65870878.618,76733,23,57,325.951,72,232

26-May-2025

879

884873.15879.5516,71032,67,04,373.21,98,388

27-May-2025

879.55

882875.2878.6512,49424,26,18,942.51,53,685

28-May-2025

881.05

882.85860862.326,06458,49,67,855.553,65,369

29-May-2025

879.55

919.5875.1893.71,10,4663,54,10,86,273.79,45,541

30-May-2025

890

897.95880.35883.429,10155,87,37,017.653,27,389

02-Jun-2025

885

885869.3878.125,34333,42,68,142.151,82,966

03-Jun-2025

878.1

879.95860862.130,54240,79,16,304.12,71,559

04-Jun-2025

862.4

868.55853.25858.9522,83931,34,90,884.71,63,066

05-Jun-2025

859.9

869.9857.7861.7520,77731,87,37,082.851,97,477

06-Jun-2025

862

866.45852.55858.326,34630,44,94,479.451,94,436

09-Jun-2025

861

870.1860.4863.121,97239,56,04,449.12,98,479

Natco Pharma: Related NEWS

Natco Pharma Q4 Net Profit Rises 5% YoY to ₹406 Crore
30 May 2025|12:15 AM

Quarterly revenue came in at ₹1,287.3 crore, a 16% YoY increase from ₹1,110.3 crore in Q4 FY24, led by robust performance in key segments.

Read More
Natco Pharma Gets USFDA Approval for Bosentan 32mg Tablets
12 Feb 2025|11:14 AM

The drug enhances the flow of blood through the lungs, allowing children with PAH to breathe and improve their ability to engage in physical activity.

Read More
Natco Pharma Sells Telangana Land for ₹115.57 Crore
1 Dec 2024|07:16 PM

The company was ensured that the sale of the land and building did not constitute part of its operational assets so that the sale will, in no way, impact the company's business operations

Read More
Natco Pharma Q2 Profit Surges 83%, Declares Interim Dividend
12 Nov 2024|10:26 PM

The revenue for the September quarter rose by 33% to ₹1,371 crore from ₹1,031 crore in the corresponding period last year.

Read More
Natco Pharma settles US patent case over generic Ozempic
7 Oct 2024|01:52 PM

According to data from the BSE index, the stock has achieved multibagger gains over the last two years, climbing 122.04%.

Read More
Cancer Patients Benefit as GST on Medications Slashed
10 Sep 2024|12:22 PM

The plan to reduce the GST on these drugs aims to significantly reduce the overall cost of cancer treatment.

Read More
Natco Pharma invests $8 million in US biotech firm eGenesis
4 Sep 2024|03:28 PM

Natco Pharma disclosed that its subsidiary will invest USD 8 million in eGenesis, acquiring a total of 40,629,761 shares.

Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.